TAU researchers devise a novel probe to identify and measure microscopic cell activity
Chemiluminescence, or chemical light, is the principle behind the glow sticks (also known as light sticks) used at rock concerts and as quick tools to grab when the electricity goes out. But they can also be used to diagnose diseases by identifying concentrations of biological samples. A new mechanism developed by Tel Aviv University researchers produces a 3,000-times-brighter, water-resistant chemiluminescent probe with particular application to medical and cancer diagnosis.
The research found that tweaking the electronic structure of current probes improves their inherent fluorescence. This could lead to the invention of a new single-component system with multiple applications — including the detection and measurement of cellular activity that points to certain pathologies, such as cancer. The study was recently published in ACS Central Science.
Chemical structure of the “glow stick” probe.
“Chemiluminescence is considered one of the most sensitive methods used in diagnostic testing,” said Prof. Doron Shabat of TAU’s School of Chemistry, who led the research. “We have developed a method to prepare highly efficient compounds that emit light upon contact with a specific protein or chemical. These compounds can be used as molecular probes to detect cancerous cells, among other applications.”
Fixing a glitch
The research, conducted in collaboration with Dr. Christoph Bauer of Geneva University, repairs an energy-loss “glitch” in current chemiluminescent probes. Most systems use a mixture of one emitter molecule that detects the species of interest, and another two additional ingredients — a fluorophore and a soap-like substance called a surfactant — that amplify the signal to detectable levels. But energy is lost in the transfer process from the emitter molecule to the fluorophore, and surfactants are not biocompatible.
“As synthetic chemists, we knew how to link structure and function,” said Prof. Shabat. “By adding two key atoms, we created a much brighter probe than those currently on the market. In addition, this particular molecule is suitable for direct use in cells.”
Based on this molecule, the researchers developed sensors to detect several biologically relevant chemicals. They also used the chemiluminescent molecule to measure the activity of several enzymes and to image cells by microscopy.
“This gives us a new powerful methodology with which we can prepare highly efficient chemiluminescence sensors for the detection, imaging and analysis of various cell activities,” said Prof. Shabat. The researchers are currently exploring ways of amplifying the chemiluminescence of the new probes for in vivo imaging.
Learn more: A Glow Stick That Detects Cancer?
The Latest on: Cancer detection
- 10 ways to reduce your cancer riskon March 22, 2020 at 6:54 pm
We recognize everyone is monitoring the rapidly evolving situation of COVID-19. That is and will remain our main focus, however, we'd like to offer these tips for taking care of ourselves when it ...
- Prostate cancer study finds molecular imaging could transform management of patients with aggressive canceron March 22, 2020 at 1:34 pm
A medical imaging technique known as PSMA PET/CT that provides detailed body scans while detecting levels of a molecule associated with prostate cancer could help doctors better tailor treatments for ...
- Bone Cancer Diagnosis and Therapeutics Market 2020 Seeking Growth from Emerging Markets, Study Drivers, Restraints and Forecast 2024on March 22, 2020 at 6:03 am
The Global “Bone Cancer Diagnosis and Therapeutics“Market Report 2020report supplies thorough estimation to improvement a complete information of the global Bone Cancer Diagnosis and Therapeutics ...
- Study: African American men less likely to use targeted prostate cancer detection methodon March 20, 2020 at 2:40 pm
Sidana is also a UC Health urologist. “Black men have a significantly higher incidence and are up to three times more likely to die of prostate cancer than white men,” says Sidana, corresponding ...
- Navigating a new cancer diagnosis during a pandemic: ‘Everything is upended’on March 20, 2020 at 2:33 pm
Robin McGee has been here before. When she was diagnosed with a recurrence of colorectal cancer on Monday, it marked the third time she's been told she has cancer. But this time, the diagnosis came in ...
via Google News and Bing News